Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11318164
Immunotherapeutic treatment method using an interleukin-2 receptor beta-selective agonist in combination with adoptive cell transfer therapy
granted -
US 11318091
Gastroretentive dosage forms for sustained drug delivery
granted -
US 11318205
IRAK degraders and uses thereof
granted -
US 11319302
PRC1 inhibitors and methods of treatment therewith
granted -
EP 3986378
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN IN FORM VON GEL MIT XYLOGLUCAN UND ALKOHOLEN ZUR KONTROLLIERTEN FREISETZUNG VON WIRKSTOFFEN
granted -
US 11311507
Enterically coated cysteamine, cystamine and derivatives thereof
granted -
US 11311547
Antiviral prodrugs and nanoformulations thereof
granted -
US 11312953
Compositions and methods of nucleic acid-targeting nucleic acids
granted -
US 11312787
Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis
granted -
US 11312962
Modulators of diacyglycerol acyltransferase 2 (DGAT2)
granted -
US 11311581
Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions
granted -
US 11311503
Sterile aqueous choline salt compositions
granted -
US 11313868
Methods of detecting anti-folic acid antibodies and uses thereof
granted -
US 11312964
Compositions and methods for modulating growth hormone receptor expression
granted -
US 11312957
Modified iRNA agents
granted -
US 11312939
Constructs for chimeric antigen receptors
granted -
US 11312756
Engineered potent cytotoxic stapled BH3 peptides
granted -
US 11312749
Heterotandem bicyclic peptide complex
granted -
US 11312786
Oncofetal antigen binding proteins and related compositions and methods
granted -
US 11312714
Compositions and methods for modulating hair growth
granted -
US 11312695
Nutrients to enhance load-induced muscle hypertrophy
granted -
US 11311624
Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds
granted -
US 11312692
Polymorphic compounds and uses thereof
granted -
US 11311613
Development of agonist epitopes of the human papillomavirus
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.